Why TARS? Tarsus Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
TARS
$63.62+0.01 (+0.02%)
Market ClosedLast close May 1
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.